\
&
Contact us
\
&
Contact us
Published on | 2 months ago
ProgrammesThe European Partnership for Pandemic Preparedness BE READY, coordinated by ANRS Emerging Infectious Diseases (ANRS MIE/Inserm), officially started its activities on 1 January 2026.
Later this month (January 2026), the Partnership will launch its first Joint Transnational Call for Proposals for multinational interdisciplinary research projects. The topic of the 2026 Call is Advancing knowledge of host and pathogen dynamics to better combat emerging diseases. The call will support innovative, collaborative, interdisciplinary and transnational research projects aiming for a better understanding of the pandemic potential of emerging pathogens, elucidating the pathophysiology induced by these pathogens, and developing innovative medical countermeasures.
Research Foundation Flanders (FWO) plans to participate in this call. More information on available funding for researchers based in Flanders and on how to apply will become available on the FWO website once the call is launched. Questions on available funding by FWO? Contact europe@fwo.be.
More information is available here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
